Alterations of T cell receptor Vβ repertoire of CD8 T lymphocytes in immune tolerance induction in two hemophilia A patients with inhibitors;Promene Vβ repertoara T-ćelijskog receptora CD8 T-limfocita tokom indukcije imunološke tolerancije kod dva obolela od hemofilije A sa inhibitorima

Vojnosanitetski Pregled

Volumn 68, Issue 12, 2011, Pages 1047-1050

  Sakurai, Yoshihiko ^a   Matsutani, Takaji ^b,c   Yoshioka, Takeshi ^b   Takeda, Tomohiro ^a   Yoshioka, Akira ^a   Shima, Midori ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alpha beta; Antigen; Factor VIII; Hemophilia a; Immune tolerance; Receptors; T cell

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLONAL VARIATION; COMPLEMENTARITY DETERMINING REGION; HEMOPHILIA A; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFANT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN DETERMINATION; PROTEIN VARIANT; T LYMPHOCYTE SUBPOPULATION; TREATMENT RESPONSE;

BLOOD COAGULATION FACTOR INHIBITORS; CD8-POSITIVE T-LYMPHOCYTES; CLONE CELLS; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; INFANT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS;

EID: 82955165138     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1112047S     Document Type: Article

References (12)

1. Hoyer LW. The incidence of factor VIII inhibitors in patients with severe hemophilia A. Adv Exp Med Biol 1995; 386: 35-45.
2. Brackmann HH, Gormsen J. Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder. Lancet 1977; 2(8044): 933.
3. Freiburghaus C, Berntorp E, Ekman M, Gunnarsson M, Kjellberg BM, Nilsson IM. Tolerance induction using the Malmo treatment model 1982-1995. Haemophilia 1999; 5(1): 32-9.
4. Mauser-Bunschoten EP, Nieuwenhuis HK, Roosendaal G, van den Berg HM. Low-dose immune tolerance induction in hemophilia A patients with inhibitors. Blood 1995; 86(3): 983-8.
5. Oldenburg J, Schwaab R, Brackmann HH. Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn Protocol': predictive parameter for therapy duration and outcome. Vox Sang 1999; 77(Suppl 1): 49-54.
6. Matsutani T, Sakurai Y, Yoshioka T, Tsuruta Y, Suzuki R, Shima M, et al. Replacement therapy with plasma-derived factor VIII concentrates induces skew in T-cell receptor usage and clonal expansion of CD8+ T-cell in HIV-seronegative hemophilia patients. Thromb Haemost 2003; 90(2): 279-92.
7. Matsutani T, Yoshioka T, Tsuruta Y, Iwagami S, Suzuki R. Analysis of TCRAV and TCRBV repertoires in healthy individuals by microplate hybridization assay. Hum Immunol 1997; 56(1-2): 57-69.
8. Matsutani T, Yoshioka T, Tsuruta Y, Iwagami S, Toyosaki-Maeda T, Horiuchi T, et al. Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation. Br J Haematol 2000; 109(4): 759-69.
9. Misra N, Bayry J, Pashov A, Kaveri SV, D'Oiron R, Stieltjes N, et al. Restricted BV gene usage by factor VIII-reactive CD4+ T cells in inhibitor-positive patients with severe hemophilia A. Thromb Haemost 2003; 90(5): 813-22.
10. Shi Z, Okuno Y, Rifa'i M, Endharti AT, Akane K, Isobe K, et al. Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol 2009; 39(8): 2106-19.
11. Endharti AT, Rifa'I M, Shi Z, Fukuoka Y, Nakahara Y, Kawamoto Y, et al. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 2005; 175(11): 7093-7.
12. Herndon JM, Stuart PM, Ferguson TA. Peripheral deletion of antigen-specific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells. J Immunol 2005; 174(7): 4098-104.